An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline re-uptake inhibitor, in patients with DSM-III-R major depressive disorder
journal contribution
posted on 2024-07-22, 23:14authored byMichael BerkMichael Berk, AD du Plessis, M Birkett, D Richardt
An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline re-uptake inhibitor, in patients with DSM-III-R major depressive disorder